S-adenosylmethionine (SAMe) for depression, to enhance the effectiveness of conventional anti-depressants and as a possible neuro-protectant
Basic medical science applied in public health
Chronic disease management and prevention
Clinical medicine applied in public health
compare the efficacy, drug interactions and side effects of the six promising CAM treatments described in these abstracts. discuss with the panel and with colleagues the work needed to refine the outline and to make it accessible to consumers and practitioners. describe at least two examples of misunderstandings about CAM treatments for mental health conditions and how the outline can be used to correct these misunderstandings.
Keywords: Mental Health, Depression
Organization/institution whose products or services will be discussed: I will discuss uses for an over-the-counter nonprescription nutriceutical. In the U.S., nutriceuticals are labelled for general conditions, such as mood, not for specific disorders such as depression.
Qualified on the content I am responsible for because: In addition to 31 years of teaching (over 200 lectures per year) and research, I practice psychopharmacology and the integration of herbs, nutrients, and medications. I published more than 80 scientific articles, books and chapters on CAM including, 'Stop Depression Now' (1999), the book that introduced Americans to (SAMe), 'How to Use Herbs, Nutrients, and Yoga in Mental Health', Non-Drug Treatments for ADHD and “Alternative Treatments in Brain Injury” in Neuropsychiatry of Traumatic Brain Injury.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.